These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20129495)

  • 1. Calpain as a therapeutic target in traumatic brain injury.
    Saatman KE; Creed J; Raghupathi R
    Neurotherapeutics; 2010 Jan; 7(1):31-42. PubMed ID: 20129495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calpains in traumatic brain injury.
    Liu S; Yin F; Zhang J; Qian Y
    Brain Inj; 2014; 28(2):133-7. PubMed ID: 24456052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
    Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
    Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
    Cardali S; Maugeri R
    J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.
    Schoch KM; Evans HN; Brelsfoard JM; Madathil SK; Takano J; Saido TC; Saatman KE
    Exp Neurol; 2012 Aug; 236(2):371-82. PubMed ID: 22572592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update.
    Kampfl A; Posmantur RM; Zhao X; Schmutzhard E; Clifton GL; Hayes RL
    J Neurotrauma; 1997 Mar; 14(3):121-34. PubMed ID: 9104930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis.
    Liu MC; Akle V; Zheng W; Dave JR; Tortella FC; Hayes RL; Wang KK
    Biochem J; 2006 Mar; 394(Pt 3):715-25. PubMed ID: 16351572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of calpain inhibitors in traumatic brain injury: a novel approach?
    Bralic M; Stemberga V; Stifter S
    Med Hypotheses; 2012 Sep; 79(3):358-60. PubMed ID: 22726623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats.
    Huh JW; Franklin MA; Widing AG; Raghupathi R
    Dev Neurosci; 2006; 28(4-5):466-76. PubMed ID: 16943669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrP
    Rubenstein R; Wang KK; Chiu A; Grinkina N; Sharma DR; Agarwal S; Lin F; Yang Z
    Behav Brain Res; 2018 Mar; 340():29-40. PubMed ID: 27188531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions.
    Kobeissy FH; Liu MC; Yang Z; Zhang Z; Zheng W; Glushakova O; Mondello S; Anagli J; Hayes RL; Wang KK
    Mol Neurobiol; 2015 Aug; 52(1):696-709. PubMed ID: 25270371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered calpastatin protein levels following traumatic brain injury in rat.
    Newcomb JK; Pike BR; Zhao X; Banik NL; Hayes RL
    J Neurotrauma; 1999 Jan; 16(1):1-11. PubMed ID: 9989462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
    Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
    J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury.
    Kupina NC; Nath R; Bernath EE; Inoue J; Mitsuyoshi A; Yuen PW; Wang KK; Hall ED
    J Neurotrauma; 2001 Nov; 18(11):1229-40. PubMed ID: 11721741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.
    Khan M; Dhammu TS; Matsuda F; Annamalai B; Dhindsa TS; Singh I; Singh AK
    Brain Res; 2016 Jan; 1630():159-70. PubMed ID: 26596859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol ameliorates calpain-induced collapsin response mediator protein-2 proteolysis in traumatic brain injury in rats.
    Yu Y; Jian MY; Wang YZ; Han RQ
    Chin Med J (Engl); 2015 Apr; 128(7):919-27. PubMed ID: 25836613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of injury severity on regional and temporal mRNA expression levels of calpains and caspases after traumatic brain injury in rats.
    Ringger NC; Tolentino PJ; McKinsey DM; Pike BR; Wang KK; Hayes RL
    J Neurotrauma; 2004 Jul; 21(7):829-41. PubMed ID: 15307896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpain expression in the brain cortex after traumatic brain injury.
    Bralić M; Stemberga V
    Coll Antropol; 2012 Dec; 36(4):1319-23. PubMed ID: 23390828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.
    Bains M; Cebak JE; Gilmer LK; Barnes CC; Thompson SN; Geddes JW; Hall ED
    J Neurochem; 2013 Apr; 125(1):125-32. PubMed ID: 23216523
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.